AbbVie is committed to being fully transparent and compliant with our policies and disclosures.
Policies & Disclosures
At AbbVie, we’re passionate about combining advanced science with a deep knowledge of the patient experience and worldwide health care systems to help people live better, more productive lives.
AbbVie is extremely proud to support patient care through the provision of grants to healthcare and patient organisations. In addition, we take pride in helping to subsidise the cost of ongoing learning of NHS healthcare professionals (HCPs) by providing financial support to attend independent third-party medical educational events and conferences. We feel this is aligned to our commitment to support HCPs, and ultimately the health and wellbeing of the patients they serve.
Collaboration of industry with healthcare organisations, patient organisations and HCPs is essential to advance patient care, gain insights into unmet medical needs and progress the development of new medicines.
Transparency is key to ensuring that HCPs and organisations can continue to collaborate to bring new, innovative treatments to patients while ensuring that concerns about the relationship and payments (to reimburse them for their time and expertise) between HCPs/patient organisations and industry are addressed.
In accordance with the Association of the British Pharmaceutical Industry (ABPI) Code of Practice, AbbVie’s disclosure of funding support is published here.
Patient organisation funding (2015-2018):
Annually, AbbVie publishes an updated list of its financial support of European Patient Organisations. Our publication of the following report demonstrates our commitment to transparent disclosure of our financial relationships with patient organisations.
HCP/ Healthcare organisation funding:
Since2016, the ABPI has required that its members disclose payments to healthcare organisations and health professionals. AbbVie’s records may be found in the public database on the ABPI website here.
If you are an HCP and have an enquiry related to the transparency initiative, please send an email to UK.Transparency@abbvie.com
AbbVie is committed to having a remarkable impact by going beyond medicines. If you would like to apply to AbbVie for a grant, donation or charitable contribution for a cause that meets our requirements, we would like to hear from you.
If you wish to apply for a grant/donation to a Healthcare Organisation or a Charitable Contribution to a Charitable Institution from AbbVie, you can do so by completing the application form and emailing it to email@example.com.
**Applications are reviewed from January to October only. Any applications recieved following October's cut-off will be reviewed in January the following year.
Your application should also include:
- A full breakdown of funding where possible
- Any other information which you think will support your application
Your application will be reviewed by a committee, which aims to notify all applicants on the outcome of their applications on a quarterly basis.
Please ensure that you complete all fields and include all relevant information in the fields provided. Unfortunately we will not be able to consider incomplete application forms.
Please note that your application will only be approved once you have received an email confirmation that confirms a positive decision.
If you have any further questions regarding the process, kindly email the committee via the email address provided above.
GUIDANCE FOR APPLICANTS
AbbVie is committed to supporting Healthcare Organisations or Charitable Institutions. The types of project we consider for funding include:
- Aligned to healthcare well-being and not linked to pharmaceutical products (licensed or in development)
- Support the local community
- Promote STEM (Science, Technology, Engineering and Mathematics) focused-education
- Are local to Maidenhead
AbbVie will make public declarations about any grant/donation to a Healthcare Organisation or a Charitable Contribution to a Charitable Institution that AbbVie has engaged with to provide financial support. This includes, but is not limited to declarations on our website www.abbvie.co.uk.
Funding is limited and will be considered where the content of the project is wholly controlled by an independent organisation and AbbVie has no input or influence over the content. If an application has not been successful, AbbVie will consider any re-submissions for part or full funding of a grant/donation to a Healthcare Organisation or a Charitable Contribution to a Charitable Institution on a quarterly basis.
Please note that grants and donations to Healthcare Organisations cannot be exclusively linked to the use of AbbVie products and the application form must be independently completed without the input of influence of an AbbVie employee.
Projects NOT considered for funding via this process include:
- Clinical research, including Investigator Initiated Trials and Research Fellowships (NOTE – this must be requested through the UK AbbVie Medical Director in writing).
- Grants to individual healthcare professionals or commercial businesses.
- Healthcare Professionals training or development opportunities
- Travel grants to Healthcare Professionals to attend scientific conferences (NOTE - these need to be requested through your AbbVie Representative)
- Patient organisations funding (NOTE – this must be requested through the relevant AbbVie Patient Relations Representative).
- Religious programmes.
- Political party sponsorship.
- Social events (eg: Charity Balls, Student graduation celebrations).
- Gap year sponsorship or electives.
- Charity fundraising outside of the UK (eg: Climbing Mount Everest).
- Activities that occurred in the past.
- Grants and donations to Healthcare Organisations exclusively linked to the use of AbbVie products.
- Application forms completed with the input of influence of an AbbVie employee.
- Funding of start-up or operating costs of
entities (i.e., resources used by an organisation to exist such as
payment of rent for the office space, staff salary, or cost of
Healthcare Organisations: Healthcare, medical or scientific association or organisation such as a hospital, clinic, foundation, university or other teaching institution or learned society whose business address, place of incorporation or primary place of operation is in Europe or an organisation through which one or more health professionals or other relevant decision makers provide services.
Charitable Institution: Any not-for-profit institution which does not fulfil the definition of a healthcare organisation.
Patient Organisations: not-for-profit organisations (including the umbrella organisations to which they belong), mainly composed of patients and/or caregivers, that represent and/or support the needs of patients, their families and/or caregivers.
Our approach to taxes1
AbbVie is a global biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. We employ approximately 30,000 people worldwide and deliver medicines to patients in more than 170 countries. Our mission is to develop and market advanced therapies that address some of the world’s most complex and serious diseases. AbbVie’s financial performance, including management of tax expense and risk, enables that mission. We are committed to achieving our goals while operating responsibly and delivering meaningful contributions to the communities where we live and work.
Our business activities around the world incur a substantial amount and variety of business taxes. We pay corporate income taxes, customs duties, excise taxes, stamp duties, property taxes, sales and use taxes, value added taxes (VAT), employment and other business taxes at the relevant levels in all jurisdictions where applicable. The taxes we pay represent a significant contribution to the communities in which we operate.
Our tax function is managed by the corporate tax department and led by the Vice President of Tax, who reports directly to the Chief Financial Officer. The VP and CFO periodically report to the audit committee of the Board of Directors. AbbVie’s approach to the management of tax risk is grounded in proactively monitoring and complying with the relevant tax laws and regulations in the jurisdictions in which AbbVie operates in order to ensure that the correct amount of taxes are identified and paid at the correct time. Our business tax processes are subject to internal controls, AbbVie’s Global Code of Business Conduct and external audit review.
Our tax function supports the business needs of the company. Thus, business transactions and activities circumscribe our approach to taxes. We ensure that the tax positions taken are consistent with the relevant tax laws in all affected jurisdictions, and aligned with the economic substance of the business transactions to which they relate.
To address patient needs around the world, AbbVie’s operating business requires a robust global supply chain. That supply chain necessitates structures, contracts and transactions among AbbVie’s affiliated companies. Those intercompany relationships must satisfy local and international tax requirements, which are not always clear or consistent. We manage that complexity by conducting rigorous analyses, often supported by external opinions, to ensure compliance with relevant tax laws. AbbVie adheres to the arm’s-length principle in its intercompany dealings, consistent with OECD guidelines and local tax laws.
Level of tax risk we are prepared to accept
While we do not have a prescriptive level of risk, we aim to minimise the risk as far as possible. Tax risks can arise for a number of reasons, including gaps or ambiguities in local tax laws, or disagreements among tax authorities as to their respective rights to tax the profits associated with a particular transaction. We mitigate those risks in three principal ways. First, our tax processes, policies and governance function to ensure compliance with tax laws in the jurisdictions in which we operate. Second, when we identify a gap or ambiguity in local tax laws, we seek advice from external advisors to ensure that any tax positions taken are well supported. Finally, we engage with tax authorities to ensure that they have timely access to any information needed to evaluate our tax positions and rationales.
Approach to interacting with tax authorities
We are committed to creating and maintaining open and positive relationships with governments and tax authorities worldwide. We seek to identify and resolve any disagreements in a collaborative and proactive manner, including via participation in continuous audit programmes and advance pricing agreements, where available and appropriate. These programmes provide certainty for both AbbVie and tax authorities over the tax treatment of AbbVie’s business.
For a PDF copy of this Tax Strategy please click here
1 - We prepared this tax policy statement for AbbVie Ltd. and its subsidiaries to comply with the new UK requirements under paragraph 19(2), schedule 19, Finance Act 2016, and for AbbVie UK Holdco Limited, AbbVie UK Ltd., AbbVie UK Biopharmaceuticals Ltd., AbbVie Biotherapeutics Limited and AbbVie Investments Limited to comply with paragraph 22(2), schedule 19, Finance Act 2016
Joint Working between Abertawe Bro Morgannwg University Health Board and AbbVie Ltd, is focussed on delivering better healthcare outcomes for Hepatitis C patients in Swansea by improving the efficiency and effectiveness of healthcare services. An executive summary outlining Joint Working between Abertawe Bro Morgannwg University Health Board and AbbVie Ltd can be found here.
An executive summary outlining Joint Working between Leeds
Teaching Hospitals Trust and AbbVie Ltd, focussed
delivering better healthcare outcomes for rheumatology
patients in Leeds by improving the efficiency and effectiveness of healthcare services can be found here